Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness

Data collection methods

Secondary data collection
Non-interventional study

Non-interventional study design

Case-control
Case-only
Cohort
Other

Non-interventional study design, other

Case-crossover analysis
Study drug and medical condition

Medical condition to be studied

Acute hepatic failure
Population studied

Short description of the study population

Patients admitted with a primary diagnosis of acute toxic liver injury.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Hepatic impaired

Estimated number of subjects

4800000
Study design details

Main study objective

To identify the main drugs associated with DILIH in France and the event rates associated with DILIH, for individual drugs and for drug families, in terms of absolute and relative risks

Data analysis plan

Descriptive: For categorical and ordinal variables will provide the number and the frequency of each modality as well as missing data. For quantitative variables will provide mean, standard deviation, first quartile, median, third quartile, and extreme values. Case-population: The main study analysis. Number of cases exposed to a given drug is compared to the number of subjects using the drug within the study time-frame, or to the number of defined daily doses (DDD) dispensed in the database population. Case-crossover: One or more control periods will be selected, one year before ID to take into account possible seasonal variations in drug use, or randomly within the year previous to ID. Case-control: Within the database population, controls will be selected, matched on age, gender, concomitant chronic diseases. Cohort: If events are enough, incident user cohorts and controls, adjusted or matched on propensity scores will be built and followed using cox proportional hazards analyses.
Documents